Search results
COVID can seriously damage your vision, even if you didn’t have symptoms, new study says. Experts...
Fortune via Yahoo Finance· 13 hours agoThat said, immunocompromised people and...
MacTel2 Treatment: With Easier Ways to Adapt to Vision Loss
Verywell Health via Yahoo News· 9 hours agoSome clinical trials involve gaining access to potential therapies that may be helpful in improving ...
Study indicates positive outcomes for new approach to Medicare/Medicaid dual enrollment
Medical Xpress· 4 hours agoA team of researchers from William & Mary, Virginia Commonwealth University and the Virginia...
Analysis-South Africa's unity government must harmonise wildly different visions
Reuters via Yahoo News· 17 hours agoHow well the African National Congress (ANC) harmonises these divergent and mutually hostile visions...
The Wild Robot Preview: Lupita Nyong’o & More Talk DreamWorks Movie
SuperHeroHype via Yahoo News· 7 hours agoShe gets the chip, but runs from the bear and falls into a bird’s nest, killing a goose and smashing...
New Research from GRF-funded Investigators Reports | Newswise
Newswise· 17 hours agoThe research was made possible through the Catalyst for a Cure Vision Restoration Initiative (CFC3)...
Heat waves hit harder for people with disabilities: Study finds increased emergency visits in South...
Medical Xpress· 1 hour agoPrevious research on the impact of these changes has revealed that extreme heat disproportionately...
DOTZON Study: Digital City Brands 2024
CircleID· 4 hours agoAfter introducing the study in early 2017, DOTZON has mapped how successful cities are using their Digital City Brands for the seventh year in a row. The...
Computer vision method characterizes electronic material properties 85 times faster than...
Tech Xplore· 13 hours agoBoosting the performance of solar cells, transistors, LEDs, and batteries will require better...
Skye Bioscience to stop eye disease drug development after failing mid-stage study
Reuters via Yahoo News· 1 day agoIn the 56-subject study, the eye drop, SBI-100, failed to significantly lower eye pressure in patients with primary open-angle glaucoma when compared with the placebo, the ...